CASE STUDY
The Employer Experience Proposition
Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
- 01Digital marketing – More important than ever
- 02Commercial innovation
- 03Post-pandemic era: An accelerator of digital transformation
- 04Importance of developing the right content
- 05Future of pharma sales & marketing
- 06Customer centricityand customer engagement
CASE STUDY
The Employer Experience Proposition
Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
- 01Digital marketing – More important than ever
- 02Commercial innovation
- 03Post-pandemic era: An accelerator of digital transformation
- 04Importance of developing the right content
- 05Future of pharma sales & marketing
- 06Customer centricityand customer engagement
Speakers
Sample of Keynote Speakers and their Case Studies
CASE STUDY
The Employer Experience Proposition
Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.
- 01Digital marketing – More important than ever
- 02Commercial innovation
- 03Post-pandemic era: An accelerator of digital transformation
- 04Importance of developing the right content
- 05Future of pharma sales & marketing
- 06Customer centricityand customer engagement
CASE STUDY
AI and Human Touch: Transforming Pharma Sales Reps for 2030
Explore how AI and human expertise are transforming the role of Pharma Sales Representatives in the specialty business. This talk will analyse the synergistic potential of AI tools and the irreplaceable human touch, highlighting strategies for success in 2030 and beyond.
- 01Explore AI-driven opportunities and challenges for Pharma Sales Reps while adapting to new technologies
- 02Provide actionable strategies for Pharma Sales Reps to leverage AI tools effectively while maintaining their essential human touch
- 03Emphasise the irreplaceable value of human interaction and trust-building in Pharma Sales, even in an AI-driven future
In this session, I’ll explore the critical role of being the bridge between product and technology, where true product development excellence happens. Drawing on my experience in transformation, including agile transformation and large-scale delivery, I’ll share how connecting vision with execution, and people with purpose leads to better collaboration, stronger outcomes, and more impactful products — the cornerstone of product and agile excellence.
CASE STUDY
Beyond Algorithms: How Human-Centred AI is Transforming Marketing and HCP Engagement
In the race to digitise and automate, pharma risks losing sight of the one thing that has always driven meaningful engagement — human connection. While AI has unlocked new levels of targeting, prediction and personalisation, the real transformation begins when we embed empathy, ethics and human insight into our algorithms.
In this session, I will share real-world experiences from our journey of integrating AI at Fresenius Kabi. From reimagining omnichannel strategies to enabling medical reps with intelligent tools, we learned how to turn AI into an enabler of trust, not just efficiency.
- 01Why human-centred AI matters more than ever in healthcare communication
- 02How predictive models can enhance — not replace — field force intuition
- 03Real-life use cases: enabling sales teams with AI-powered insights without losing the human touch
- 04The evolving role of the marketer: from content creator to experience architect
Pre-Start Phase:
1.Patient Safety Review:
- Assess patient demographics, drug specifics, AE (Adverse Event) incidence rates, available resources, and programme design fundamentals
- Integrate multifaceted support resources, including call centres, educational materials, and digital tools
2.Contracting Essentials:
- Determine the need for standalone PVAs (Pharmacovigilance Agreements) or safety clauses
- Critical contract elements: Include audit rights, clear definitions, mandatory training, AE reporting procedures, contact details, and reconciliation processes
3.AE Training and Vendor Setup:
- Implement comprehensive AE training protocols
- Establish a robust vendor monitoring strategy with clear KPIs, defined monitoring frequency, and audit readiness
During the Programme:
1.Vendor Performance and AE Monitoring:
- Conduct regular vendor reviews to ensure compliance with contractual obligations
- Maintain ongoing reconciliation and monitor AE trends to identify any emerging issues
Post Completion:
1.Study Reporting:
- Prepare a comprehensive study report summarising outcomes, key learnings, and areas for improvement
CASE STUDY
Pharma Marketing Overdue for a Revolution
Pharma marketing is stuck in the past. Outdated strategies and missed opportunities are holding us back. The time for change is NOW. Together, we will uncover bold, innovative approaches that will redefine how we connect with our customers and harness digital tools to lead the industry into the future. This isn’t just evolution; it’s a revolution. Don’t get left behind.
- 01Internal vs External Triggers for EWIs
- 02Timing of EWI Identification — Why It Matters
- 03Dynamics of EWI Importance — Client vs Bank Perspective
- 04Case Study — EWI Success Story
In an evolving landscape where customer expectations continually rise, understanding and proactively addressing customer needs is no longer optional—it’s essential. This session explores how empathy-driven customer experience (CX), combined with strategic automation and cutting-edge AI, can radically enhance efficiency, agent performance, and customer loyalty. Leveraging real-world insights and innovative frameworks, discover practical ways to future-proof your contact centre operations.
CASE STUDY
Notes for a Correct Approach to Omnichannel
Omnichannel and Multichannel start from a common base: the use of different channels to communicate with customers. These channels are sometimes used without considering the impact they can have on customers — HCPs. Additionally, there is the possibility of using a greater number of channels to make them even more effective if used in an integrated manner (Kotler, 2022). The most used channels or touchpoints are:
- 01Online: remote call (single or group), approved mail, webinar, online congresses (widely used during the Covid period)
- 02Offline: F2F, phone calls, hospital meetings, congresses
This Omnichannel ecosystem adapts to the needs of HCPs, evolving with them in the choice of channels and topics to ensure that the HCP’s decision-making process is completed: 1) knowledge, 2) interest, 3) request, 4) action/use, 4) support (Kotler, 2022). All this leads us to “customer engagement” according to the principle: the right content, the right person, the right place (Schmitt, 2003).
CASE STUDY
Customer Experience & AI in Pharma: Are Humans Still Invited?
In today’s complex environments, a one-size-fits-all SIEM is no longer realistic. Security, compliance, and visibility needs vary across organisations — and even within them.
- 01Level-based model aligned with business risk, regulatory pressure, and operational maturity
- 02Coexistence of multiple SIEMs, leveraging each tool’s strengths (e.g., analytics, integrations, scalability)
- 03Enhanced visibility as a core driver — moving from log collection to real-time insight and actionable intelligence
In today’s rapidly evolving digital landscape, businesses must innovate to stay ahead. AI is no longer just an advantage — it’s a necessity for optimising operations, enhancing decision-making, and driving growth. This presentation explores how AI transforms business operations through:
CASE STUDY
AI and Human Touch: Transforming Pharma Sales Reps for 2030
Explore how AI and human expertise are transforming the role of Pharma Sales Representatives in the specialty business. This talk will analyse the synergistic potential of AI tools and the irreplaceable human touch, highlighting strategies for success in 2030 and beyond.
- 01Explore AI-driven opportunities and challenges for Pharma Sales Reps while adapting to new technologies
- 02Provide actionable strategies for Pharma Sales Reps to leverage AI tools effectively while maintaining their essential human touch
- 03Emphasise the irreplaceable value of human interaction and trust-building in Pharma Sales, even in an AI-driven future
In this session, I’ll explore the critical role of being the bridge between product and technology, where true product development excellence happens. Drawing on my experience in transformation, including agile transformation and large-scale delivery, I’ll share how connecting vision with execution, and people with purpose leads to better collaboration, stronger outcomes, and more impactful products — the cornerstone of product and agile excellence.
CASE STUDY
Beyond Algorithms: How Human-Centred AI is Transforming Marketing and HCP Engagement
In the race to digitise and automate, pharma risks losing sight of the one thing that has always driven meaningful engagement — human connection. While AI has unlocked new levels of targeting, prediction and personalisation, the real transformation begins when we embed empathy, ethics and human insight into our algorithms.
In this session, I will share real-world experiences from our journey of integrating AI at Fresenius Kabi. From reimagining omnichannel strategies to enabling medical reps with intelligent tools, we learned how to turn AI into an enabler of trust, not just efficiency.
- 01Why human-centred AI matters more than ever in healthcare communication
- 02How predictive models can enhance — not replace — field force intuition
- 03Real-life use cases: enabling sales teams with AI-powered insights without losing the human touch
- 04The evolving role of the marketer: from content creator to experience architect
Pre-Start Phase:
1.Patient Safety Review:
- Assess patient demographics, drug specifics, AE (Adverse Event) incidence rates, available resources, and programme design fundamentals
- Integrate multifaceted support resources, including call centres, educational materials, and digital tools
2.Contracting Essentials:
- Determine the need for standalone PVAs (Pharmacovigilance Agreements) or safety clauses
- Critical contract elements: Include audit rights, clear definitions, mandatory training, AE reporting procedures, contact details, and reconciliation processes
3.AE Training and Vendor Setup:
- Implement comprehensive AE training protocols
- Establish a robust vendor monitoring strategy with clear KPIs, defined monitoring frequency, and audit readiness
During the Programme:
1.Vendor Performance and AE Monitoring:
- Conduct regular vendor reviews to ensure compliance with contractual obligations
- Maintain ongoing reconciliation and monitor AE trends to identify any emerging issues
Post Completion:
1.Study Reporting:
- Prepare a comprehensive study report summarising outcomes, key learnings, and areas for improvement
CASE STUDY
Customer Experience & AI in Pharma: Are Humans Still Invited?
In today’s complex environments, a one-size-fits-all SIEM is no longer realistic. Security, compliance, and visibility needs vary across organisations — and even within them.
- 01Level-based model aligned with business risk, regulatory pressure, and operational maturity
- 02Coexistence of multiple SIEMs, leveraging each tool’s strengths (e.g., analytics, integrations, scalability)
- 03Enhanced visibility as a core driver — moving from log collection to real-time insight and actionable intelligence
In today’s rapidly evolving digital landscape, businesses must innovate to stay ahead. AI is no longer just an advantage — it’s a necessity for optimising operations, enhancing decision-making, and driving growth. This presentation explores how AI transforms business operations through:
CASE STUDY
Pharma Marketing Overdue for a Revolution
Pharma marketing is stuck in the past. Outdated strategies and missed opportunities are holding us back. The time for change is NOW. Together, we will uncover bold, innovative approaches that will redefine how we connect with our customers and harness digital tools to lead the industry into the future. This isn’t just evolution; it’s a revolution. Don’t get left behind.
- 01Internal vs External Triggers for EWIs
- 02Timing of EWI Identification — Why It Matters
- 03Dynamics of EWI Importance — Client vs Bank Perspective
- 04Case Study — EWI Success Story
In an evolving landscape where customer expectations continually rise, understanding and proactively addressing customer needs is no longer optional—it’s essential. This session explores how empathy-driven customer experience (CX), combined with strategic automation and cutting-edge AI, can radically enhance efficiency, agent performance, and customer loyalty. Leveraging real-world insights and innovative frameworks, discover practical ways to future-proof your contact centre operations.
CASE STUDY
Notes for a Correct Approach to Omnichannel
Omnichannel and Multichannel start from a common base: the use of different channels to communicate with customers. These channels are sometimes used without considering the impact they can have on customers — HCPs. Additionally, there is the possibility of using a greater number of channels to make them even more effective if used in an integrated manner (Kotler, 2022). The most used channels or touchpoints are:
- 01Online: remote call (single or group), approved mail, webinar, online congresses (widely used during the Covid period)
- 02Offline: F2F, phone calls, hospital meetings, congresses
This Omnichannel ecosystem adapts to the needs of HCPs, evolving with them in the choice of channels and topics to ensure that the HCP’s decision-making process is completed: 1) knowledge, 2) interest, 3) request, 4) action/use, 4) support (Kotler, 2022). All this leads us to “customer engagement” according to the principle: the right content, the right person, the right place (Schmitt, 2003).
CASE STUDY
AI and Human Touch: Transforming Pharma Sales Reps for 2030
Explore how AI and human expertise are transforming the role of Pharma Sales Representatives in the specialty business. This talk will analyse the synergistic potential of AI tools and the irreplaceable human touch, highlighting strategies for success in 2030 and beyond.
- 01Explore AI-driven opportunities and challenges for Pharma Sales Reps while adapting to new technologies
- 02Provide actionable strategies for Pharma Sales Reps to leverage AI tools effectively while maintaining their essential human touch
- 03Emphasise the irreplaceable value of human interaction and trust-building in Pharma Sales, even in an AI-driven future
In this session, I’ll explore the critical role of being the bridge between product and technology, where true product development excellence happens. Drawing on my experience in transformation, including agile transformation and large-scale delivery, I’ll share how connecting vision with execution, and people with purpose leads to better collaboration, stronger outcomes, and more impactful products — the cornerstone of product and agile excellence.
CASE STUDY
Beyond Algorithms: How Human-Centred AI is Transforming Marketing and HCP Engagement
In the race to digitise and automate, pharma risks losing sight of the one thing that has always driven meaningful engagement — human connection. While AI has unlocked new levels of targeting, prediction and personalisation, the real transformation begins when we embed empathy, ethics and human insight into our algorithms.
In this session, I will share real-world experiences from our journey of integrating AI at Fresenius Kabi. From reimagining omnichannel strategies to enabling medical reps with intelligent tools, we learned how to turn AI into an enabler of trust, not just efficiency.
- 01Why human-centred AI matters more than ever in healthcare communication
- 02How predictive models can enhance — not replace — field force intuition
- 03Real-life use cases: enabling sales teams with AI-powered insights without losing the human touch
- 04The evolving role of the marketer: from content creator to experience architect
Pre-Start Phase:
1.Patient Safety Review:
- Assess patient demographics, drug specifics, AE (Adverse Event) incidence rates, available resources, and programme design fundamentals
- Integrate multifaceted support resources, including call centres, educational materials, and digital tools
2.Contracting Essentials:
- Determine the need for standalone PVAs (Pharmacovigilance Agreements) or safety clauses
- Critical contract elements: Include audit rights, clear definitions, mandatory training, AE reporting procedures, contact details, and reconciliation processes
3.AE Training and Vendor Setup:
- Implement comprehensive AE training protocols
- Establish a robust vendor monitoring strategy with clear KPIs, defined monitoring frequency, and audit readiness
During the Programme:
1.Vendor Performance and AE Monitoring:
- Conduct regular vendor reviews to ensure compliance with contractual obligations
- Maintain ongoing reconciliation and monitor AE trends to identify any emerging issues
Post Completion:
1.Study Reporting:
- Prepare a comprehensive study report summarising outcomes, key learnings, and areas for improvement
CASE STUDY
Pharma Marketing Overdue for a Revolution
Pharma marketing is stuck in the past. Outdated strategies and missed opportunities are holding us back. The time for change is NOW. Together, we will uncover bold, innovative approaches that will redefine how we connect with our customers and harness digital tools to lead the industry into the future. This isn’t just evolution; it’s a revolution. Don’t get left behind.
- 01Internal vs External Triggers for EWIs
- 02Timing of EWI Identification — Why It Matters
- 03Dynamics of EWI Importance — Client vs Bank Perspective
- 04Case Study — EWI Success Story
In an evolving landscape where customer expectations continually rise, understanding and proactively addressing customer needs is no longer optional—it’s essential. This session explores how empathy-driven customer experience (CX), combined with strategic automation and cutting-edge AI, can radically enhance efficiency, agent performance, and customer loyalty. Leveraging real-world insights and innovative frameworks, discover practical ways to future-proof your contact centre operations.
CASE STUDY
Notes for a Correct Approach to Omnichannel
Omnichannel and Multichannel start from a common base: the use of different channels to communicate with customers. These channels are sometimes used without considering the impact they can have on customers — HCPs. Additionally, there is the possibility of using a greater number of channels to make them even more effective if used in an integrated manner (Kotler, 2022). The most used channels or touchpoints are:
- 01Online: remote call (single or group), approved mail, webinar, online congresses (widely used during the Covid period)
- 02Offline: F2F, phone calls, hospital meetings, congresses
This Omnichannel ecosystem adapts to the needs of HCPs, evolving with them in the choice of channels and topics to ensure that the HCP’s decision-making process is completed: 1) knowledge, 2) interest, 3) request, 4) action/use, 4) support (Kotler, 2022). All this leads us to “customer engagement” according to the principle: the right content, the right person, the right place (Schmitt, 2003).
CASE STUDY
Customer Experience & AI in Pharma: Are Humans Still Invited?
In today’s complex environments, a one-size-fits-all SIEM is no longer realistic. Security, compliance, and visibility needs vary across organisations — and even within them.
- 01Level-based model aligned with business risk, regulatory pressure, and operational maturity
- 02Coexistence of multiple SIEMs, leveraging each tool’s strengths (e.g., analytics, integrations, scalability)
- 03Enhanced visibility as a core driver — moving from log collection to real-time insight and actionable intelligence
In today’s rapidly evolving digital landscape, businesses must innovate to stay ahead. AI is no longer just an advantage — it’s a necessity for optimising operations, enhancing decision-making, and driving growth. This presentation explores how AI transforms business operations through: